Papers

5

Total Citations

57

H-Index

3

About

Dr. Hirotaka Konishi is a leading Japanese surgical oncologist whose research focuses on advancing minimally invasive and radical surgical approaches for esophageal and gastric cancers. His most impactful work, a 2019 study on the transmediastinal approach for esophageal cancer (40 citations), has helped define a new trend toward radical surgery for esophageal squamous cell carcinoma (ESCC), a prevalent and aggressive disease in Asia. Dr. Konishi is also at the forefront of robotic surgery, demonstrating through comparative studies that robotic distal gastrectomy (RDG) offers advantages over conventional laparoscopic methods for gastric cancer. His recent investigations into postoperative complications are particularly notable; he identified pancreatic fistula as a pivotal prognostic factor strongly linked to poor outcomes and recurrence after gastrectomy, while highlighting that robotic gastrectomy may virtually eliminate this risk. Further, he has developed innovative risk assessment models using intraoperative image analysis to predict pancreatic fistula during laparoscopic and robotic procedures. With a growing body of work that directly translates to improved patient safety and surgical precision, Dr. Konishi is shaping the future of oncologic surgery in Asia.

Research Focus

Key Achievements

3
H-Index
5
Papers
57
Total Citations
11
Avg Citations/Paper
🏆 Most Cited Paper
Transmediastinal approach for esophageal cancer: A new trend toward radical surgery
40 citations · 2019
📈 Most Prolific Year: 2019 (2 Papers)
🤝 Key Collaborators: 24
🏛 Institutions: Kyoto Prefectural University, Kyoto Prefectural University of Medicine

Top Papers

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 15 days ago